Lifeist Wellness (LFSWF) Ratios

227 Followers

Lifeist Wellness Ratios

LFSWF's free cash flow for Q4 2025 was C$-2.77. For the 2025 fiscal year, LFSWF's free cash flow was decreased by C$ and operating cash flow was C$-6.87. See a summary of the company’s cash flow.

Ratios	TTM	Feb 26	Feb 25	Feb 24	Feb 23
Liquidity Ratios
Current Ratio	―	2.67	3.42	0.97	2.11
Quick Ratio	―	2.21	3.34	0.47	1.48
Cash Ratio	―	1.14	2.21	0.16	0.53
Solvency Ratio	―	-4.33	-1.34	-1.29	-1.91
Operating Cash Flow Ratio	―	-4.21	-0.83	-0.27	-2.16
Short-Term Operating Cash Flow Coverage	―	0.00	0.00	0.00	0.00
Net Current Asset Value	C$ ―	C$ 1.15M	C$ 2.56M	C$ -1.16M	C$ 7.75M
Leverage Ratios
Debt-to-Assets Ratio	―	0.00	0.00	0.09	0.02
Debt-to-Equity Ratio	―	0.00	0.00	0.37	0.02
Debt-to-Capital Ratio	―	0.00	0.00	0.27	0.02
Long-Term Debt-to-Capital Ratio	―	0.00	0.00	0.00	0.00
Financial Leverage Ratio	―	1.60	1.26	3.87	1.55
Debt Service Coverage Ratio	―	0.00	-114.82	-248.81	-7.01K
Interest Coverage Ratio	―	0.00	-127.50	-257.75	-6.03K
Debt to Market Cap	―	0.00	0.00	0.00	0.00
Interest Debt Per Share	―	0.00	<0.01	0.05	0.02
Net Debt to EBITDA	―	0.33	0.59	0.03	0.20
Profitability Margins
Gross Profit Margin	―	-339.01%	34.77%	24.67%	17.20%
EBIT Margin	―	-961.10%	-682.57%	-27.79%	-85.72%
EBITDA Margin	―	-958.13%	-678.16%	-27.53%	-79.04%
Operating Profit Margin	―	-961.10%	-753.05%	-28.39%	-67.09%
Pretax Profit Margin	―	-1198.99%	-688.52%	-27.90%	-85.73%
Net Profit Margin	―	-1198.99%	-245.58%	-65.22%	-69.94%
Continuous Operations Profit Margin	―	-1198.99%	-688.52%	-27.78%	-84.72%
Net Income Per EBT	―	100.00%	35.67%	233.76%	81.58%
EBT Per EBIT	―	124.75%	91.43%	98.26%	127.79%
Return on Assets (ROA)	―	-162.89%	-28.17%	-105.42%	-74.68%
Return on Equity (ROE)	―	-260.69%	-35.51%	-408.45%	-115.49%
Return on Capital Employed (ROCE)	―	-208.97%	-108.88%	-142.13%	-109.29%
Return on Invested Capital (ROIC)	―	-208.97%	-108.88%	-129.63%	-106.85%
Return on Tangible Assets	―	-162.89%	-28.78%	-123.07%	-83.05%
Earnings Yield	―	-121.41%	-101.10%	-289.55%	-57.03%
Efficiency Ratios
Receivables Turnover	―	0.37	0.51	9.29	3.80
Payables Turnover	―	3.21	2.15	6.21	7.71
Inventory Turnover	―	3.46	4.77	3.62	3.77
Fixed Asset Turnover	―	0.00	79.47	8.66	7.13
Asset Turnover	―	0.14	0.11	1.62	1.07
Working Capital Turnover Ratio	―	0.13	0.52	5.67	1.82
Cash Conversion Cycle	―	971.00	622.49	81.41	145.48
Days of Sales Outstanding	―	979.06	716.04	39.29	96.02
Days of Inventory Outstanding	―	105.49	76.45	100.92	96.79
Days of Payables Outstanding	―	113.55	170.00	58.80	47.32
Operating Cycle	―	1.08K	792.49	140.21	192.81
Cash Flow Ratios
Operating Cash Flow Per Share	―	-0.08	-0.03	-0.10	-0.74
Free Cash Flow Per Share	―	-0.08	-0.03	-0.11	-0.77
CapEx Per Share	―	<0.01	0.00	<0.01	0.03
Free Cash Flow to Operating Cash Flow	―	1.00	1.00	1.13	1.05
Dividend Paid and CapEx Coverage Ratio	―	-724.92K	0.00	-127.56	-22.13
Capital Expenditure Coverage Ratio	―	-724.92K	0.00	-127.56	-22.13
Operating Cash Flow Coverage Ratio	―	0.00	0.00	-1.94	-46.74
Operating Cash Flow to Sales Ratio	―	-11.63	-1.49	-0.11	-0.70
Free Cash Flow Yield	―	-117.75%	-61.33%	-57.24%	-59.27%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-0.82	-0.99	-0.35	-1.75
Price-to-Sales (P/S) Ratio	―	9.88	2.43	0.23	1.23
Price-to-Book (P/B) Ratio	―	2.15	0.35	1.41	2.03
Price-to-Free Cash Flow (P/FCF) Ratio	―	-0.85	-1.63	-1.75	-1.69
Price-to-Operating Cash Flow Ratio	―	-0.85	-1.63	-1.98	-1.76
Price-to-Earnings Growth (PEG) Ratio	―	-0.01	0.01	0.02	0.04
Price-to-Fair Value	―	2.15	0.35	1.41	2.03
Enterprise Value Multiple	―	-0.70	0.23	-0.79	-1.35
Enterprise Value	―	1.68M	-911.78K	4.69M	23.59M
EV to EBITDA	―	-0.70	0.23	-0.79	-1.35
EV to Sales	―	6.74	-1.55	0.22	1.07
EV to Free Cash Flow	―	-0.58	1.04	-1.68	-1.47
EV to Operating Cash Flow	―	-0.58	1.04	-1.91	-1.54
Tangible Book Value Per Share	―	0.03	0.12	0.06	0.54
Shareholders’ Equity Per Share	―	0.03	0.13	0.14	0.64
Tax and Other Ratios
Effective Tax Rate	―	0.00	0.00	<0.01	0.01
Revenue Per Share	―	<0.01	0.02	0.89	1.06
Net Income Per Share	―	-0.08	-0.05	-0.58	-0.74
Tax Burden	―	1.00	0.36	2.34	0.82
Interest Burden	―	1.25	1.01	1.00	1.00
Research & Development to Revenue	―	0.00	0.00	<0.01	<0.01
SG&A to Revenue	―	9.82	7.83	0.27	0.64
Stock-Based Compensation to Revenue	―	0.00	0.72	0.04	0.03
Income Quality	―	0.97	0.22	0.17	0.99

Currency in CAD